fda shortage tirzepatide Eli Lilly's Weight-Loss Drug Zepbound Is Officially Over: GLP-1 Saga Continues: FDA Ends

Exposure to excessive moisture, heat, direct sunlight, or frequent freeze-thaw cycles may negatively impact product stability during laboratory applications

If a patient discovers she is pregnant whilst using semaglutide, she should contact her GP or diabetes specialist immediately to discontinue the medication and arrange appropriate antenatal care

Summary: Retatrutide is not available in pill form it is administered exclusively by subcutaneous injection in clinical trials, and no oral formulation has been announced by Eli Lilly as of April 2026

those starting below 8% fell by about 1.5 to 2 points. Tirzepatide lowers glucose mainly by improving insulin sensitivity rather than forcing the pancreas to release more insulin

Feldmans research focuses on FDA regulation, pharmaceutical pricing and policy, intellectual property, and pharmacoepidemiology